On the other hand, serum FABP4 has been associated with hallmarks of MASH, including gamma-glutamyl transpeptidase (GGT) and ultra-sensitive C reactive protein (usCRP) [30], and it has been proposed as a predictive factor for intrahepatic inflammation and fibrosis confirmed by liver histology [25]. Here, FABP4 is linked to metabolic dysfunction-associated steatohepatitis.